RxSight (RXST) Change in Acquisitions & Divestments (2020 - 2026)

RxSight's Change in Acquisitions & Divestments history runs 7 years deep, the most recent figure standing at $110.0 million for Q1 2026.

• Quarterly Change in Acquisitions & Divestments rose 83.33% year-over-year to $110.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $310.0 million (up 35.37% YoY) and the FY2025 annual result came in at $260.0 million, up 7.0% from the prior year.
• Change in Acquisitions & Divestments was $110.0 million for Q1 2026 at RxSight, up from $90.0 million in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $110.0 million in Q1 2026 and bottomed at $45.0 million in Q2 2022.
• A 5-year average of $66.1 million and a median of $60.0 million in 2023 frame the typical range for Change in Acquisitions & Divestments.
• Annual changes were most pronounced in 2022 — Change in Acquisitions & Divestments soared 400.0% — and 2023, when it plunged 33.33%.
• RxSight's Change in Acquisitions & Divestments stood at $45.0 million in 2022, then advanced by 11.11% to $50.0 million in 2023, then increased by 10.0% to $55.0 million in 2024, then soared by 63.64% to $90.0 million in 2025, then increased by 22.22% to $110.0 million in 2026.
• Business Quant data shows RXST's Change in Acquisitions & Divestments at $110.0 million in Q1 2026, $90.0 million in Q4 2025, and $60.0 million in Q3 2025.